Literature DB >> 19741566

CYP2D6: novel genomic structures and alleles.

Whitney E Kramer1, Denise L Walker, Dennis J O'Kane, David A Mrazek, Pamela K Fisher, Brian A Dukek, Jamie K Bruflat, John L Black.   

Abstract

OBJECTIVE: CYP2D6 is a polymorphic gene. It has been observed to be deleted, to be duplicated and to undergo recombination events involving the CYP2D7 pseudogene and surrounding sequences. The objective of this study was to discover the genomic structure of CYP2D6 recombinants that interfere with clinical genotyping platforms that are available today.
METHODS: Clinical samples containing rare homozygous CYP2D6 alleles, ambiguous readouts, and those with duplication signals and two different alleles were analyzed by long-range PCR amplification of individual genes, PCR fragment analysis, allele-specific primer extension assay, and DNA sequencing to characterize alleles and genomic structure.
RESULTS: Novel alleles, genomic structures, and the DNA sequence of these structures are described. Interestingly, in 49 of 50 DNA samples that had CYP2D6 gene duplications or multiplications where two alleles were detected, the chromosome containing the duplication or multiplication had identical tandem alleles.
CONCLUSION: Several new CYP2D6 alleles and genomic structures are described which will be useful for CYP2D6 genotyping. The findings suggest that the recombination events responsible for CYP2D6 duplications and multiplications are because of mechanisms other than interchromosomal crossover during meiosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19741566      PMCID: PMC2862371          DOI: 10.1097/FPC.0b013e3283317b95

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  39 in total

Review 1.  Genome architecture, rearrangements and genomic disorders.

Authors:  Paweł Stankiewicz; James R Lupski
Journal:  Trends Genet       Date:  2002-02       Impact factor: 11.639

2.  New allelic arrangement CYP2D6*36 x 2 found in a Japanese poor metabolizer of debrisoquine.

Authors:  Michihiro Chida; Noritaka Ariyoshi; Tsuyoshi Yokoi; Nobuo Nemoto; Makoto Inaba; Moritoshi Kinoshita; Tetsuya Kamataki
Journal:  Pharmacogenetics       Date:  2002-11

3.  CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.

Authors:  Elke Schaeffeler; Matthias Schwab; Michel Eichelbaum; Ulrich M Zanger
Journal:  Hum Mutat       Date:  2003-12       Impact factor: 4.878

Review 4.  Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.

Authors:  J Kirchheiner; K Nickchen; M Bauer; M-L Wong; J Licinio; I Roots; J Brockmöller
Journal:  Mol Psychiatry       Date:  2004-05       Impact factor: 15.992

5.  Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6.

Authors:  U M Zanger; J Fischer; S Raimundo; T Stüven; B O Evert; M Schwab; M Eichelbaum
Journal:  Pharmacogenetics       Date:  2001-10

6.  A novel cell-free system reveals a mechanism of circular DNA formation from tandem repeats.

Authors:  S Cohen; M Mechali
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

7.  Small circular DNA in Drosophila melanogaster.

Authors:  S Stanfield; D R Helinski
Journal:  Cell       Date:  1976-10       Impact factor: 41.582

8.  Gene amplification, drug resistance, and cancer.

Authors:  R T Schimke
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

9.  Formation of extrachromosomal circles from telomeric DNA in Xenopus laevis.

Authors:  Sarit Cohen; Marcel Méchali
Journal:  EMBO Rep       Date:  2002-11-21       Impact factor: 8.807

10.  Extrachromosomal circular DNA of tandemly repeated genomic sequences in Drosophila.

Authors:  Sarit Cohen; Keren Yacobi; Daniel Segal
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

View more
  19 in total

1.  Frequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype prediction.

Authors:  John Logan Black; Denise L Walker; Dennis J O'Kane; Maria Harmandayan
Journal:  Drug Metab Dispos       Date:  2011-10-17       Impact factor: 3.922

2.  CYP2C19 variation and citalopram response.

Authors:  David A Mrazek; Joanna M Biernacka; Dennis J O'Kane; John L Black; Julie M Cunningham; Maureen S Drews; Karen A Snyder; Susanna R Stevens; Augustus John Rush; Richard M Weinshilboum
Journal:  Pharmacogenet Genomics       Date:  2011-01       Impact factor: 2.089

Review 3.  PharmVar GeneFocus: CYP2D6.

Authors:  Charity Nofziger; Amy J Turner; Katrin Sangkuhl; Michelle Whirl-Carrillo; José A G Agúndez; John L Black; Henry M Dunnenberger; Gualberto Ruano; Martin A Kennedy; Michael S Phillips; Houda Hachad; Teri E Klein; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2019-12-09       Impact factor: 6.875

4.  Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes.

Authors:  Ibrahim Numanagić; Salem Malikić; Michael Ford; Xiang Qin; Lorraine Toji; Milan Radovich; Todd C Skaar; Victoria M Pratt; Bonnie Berger; Steve Scherer; S Cenk Sahinalp
Journal:  Nat Commun       Date:  2018-02-26       Impact factor: 14.919

5.  Identification of CYP2D6 Haplotypes that Interfere with Commonly Used Assays for Copy Number Variation Characterization.

Authors:  Amy J Turner; Praful Aggarwal; Erin C Boone; Cyrine-Eliana Haidar; Mary V Relling; Ashley D Derezinski; Ulrich Broeckel; Andrea Gaedigk
Journal:  J Mol Diagn       Date:  2021-02-22       Impact factor: 5.568

6.  Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants.

Authors:  Andrea Gaedigk; Lazara Karelia Montane Jaime; Joseph S Bertino; Anick Bérard; Victoria M Pratt; L Dianne Bradfordand; J Steven Leeder
Journal:  Front Pharmacol       Date:  2010-10-04       Impact factor: 5.810

Review 7.  Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.

Authors:  Victoria M Pratt; Larisa H Cavallari; Andria L Del Tredici; Andrea Gaedigk; Houda Hachad; Yuan Ji; Lisa V Kalman; Reynold C Ly; Ann M Moyer; Stuart A Scott; R H N van Schaik; Michelle Whirl-Carrillo; Karen E Weck
Journal:  J Mol Diagn       Date:  2021-06-10       Impact factor: 5.341

8.  Cypiripi: exact genotyping of CYP2D6 using high-throughput sequencing data.

Authors:  Ibrahim Numanagić; Salem Malikić; Victoria M Pratt; Todd C Skaar; David A Flockhart; S Cenk Sahinalp
Journal:  Bioinformatics       Date:  2015-06-15       Impact factor: 6.937

9.  Establishment of CYP2D6 reference samples by multiple validated genotyping platforms.

Authors:  H Fang; X Liu; J Ramírez; N Choudhury; M Kubo; H K Im; A Konkashbaev; N J Cox; M J Ratain; Y Nakamura; P H O'Donnell
Journal:  Pharmacogenomics J       Date:  2014-07-01       Impact factor: 3.550

10.  A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication.

Authors:  Taimour Langaee; Issam Hamadeh; Arlene B Chapman; John G Gums; Julie A Johnson
Journal:  PLoS One       Date:  2015-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.